HPV16 drives cancer immune escape via NLRX1-mediated degradation of STING. PMID: 31874109
Murine HPV16 E7-expressing transgenic skin effectively emulates the cellular and molecular features of human high-grade squamous intraepithelial lesions. PMID: 29807614
HPV16 AND EXPRESSION OF PROTEIN P16INK4A AND E7 ONCOPROTEIN IN COLORECTAL CARCINOMA. PMID: 35107499
Development of a Spontaneous HPV16 E6/E7-Expressing Head and Neck Squamous Cell Carcinoma in HLA-A2 Transgenic Mice. PMID: 35089069
Evaluation of HPV16 E7 expression in head and neck carcinoma cell lines and clinical specimens. PMID: 33335126
Local radiotherapy and E7 RNA-LPX vaccination show enhanced therapeutic efficacy in preclinical models of HPV16+ cancer. PMID: 34971406
HPV16 E6 and E7 Oncoproteins Stimulate the Glutamine Pathway Maintaining Cell Proliferation in a SNAT1-Dependent Fashion. PMID: 36851539
The HPV16 E6, E7/miR-23b-3p/ICAT signaling axis promotes proliferation, migration, invasion and EMT of cervical cancer cells. PMID: 36847693
Modeling and Molecular Dynamics of the 3D Structure of the HPV16 E7 Protein and Its Variants. PMID: 33573298
HPV16 E6/E7 upregulates HIF-2α and VEGF by inhibiting LKB1 in lung cancer cells. PMID: 28720067
HPV 16 E7 alters translesion synthesis signaling. PMID: 36266721
A novel function of HPV16-E6/E7 in epithelial-mesenchymal transition. PMID: 23628416
Immunization of mice by the co-administration of codon-optimized HPV16 E7 and lL12 genes against HPV16-associated cervical cancer. PMID: 31004722
The Intracellular Delivery Of Anti-HPV16 E7 scFvs Through Engineered Extracellular Vesicles Inhibits The Proliferation Of HPV-Infected Cells. PMID: 31806970
HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. PMID: 25439690
The expression of Oct3/4A mRNA and not its isoforms is upregulated by the HPV16 E7 oncoprotein. PMID: 36378419
Significant growth inhibition by a bispecific affibody targeting oncoprotein E7 in both HPV16 and 18 positive cervical cancer in vitro and in vivo. PMID: 35245683
Association of cervical carcinogenesis risk with HPV16 E6 and E7 variants in the Taizhou area, China. PMID: 34217247
Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system. PMID: 28786561
HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3. PMID: 28260046
Epithelium Expressing the E7 Oncoprotein of HPV16 Attracts Immune-Modulatory Dendritic Cells to the Skin and Suppresses Their Antigen-Processing Capacity. PMID: 27031095
CUL2 overexpression driven by CUL2/E2F1/miR-424 regulatory loop promotes HPV16 E7 induced cervical carcinogenesis. PMID: 27153550
Apoptosis induced by an antagonist peptide against HPV16 E7 in vitro and in vivo via restoration of p53. PMID: 21475994
Non-Metabolic Functions of PKM2 Contribute to Cervical Cancer Cell Proliferation Induced by the HPV16 E7 Oncoprotein. PMID: 33800513
Distinctive distribution of HPV16 E6 D25E and E7 N29S intratypic Asian variants in Korean commercial sex workers. PMID: 17311337
Molecular and evolutionary analysis of HPV16 E6 and E7 genes in Greek women. PMID: 23946477
HPV16 E7 DNA tattooing: safety, immunogenicity, and clinical response in patients with HPV-positive vulvar intraepithelial neoplasia. PMID: 28451790
hnRNP G/RBMX enhances HPV16 E2 mRNA splicing through a novel splicing enhancer and inhibits production of spliced E7 oncogene mRNAs. PMID: 35357488
Detection of Circulating HPV16 DNA as a Biomarker for Cervical Cancer by a Bead-Based HPV Genotyping Assay. PMID: 35225653
Systematic Analysis of IL-1 Cytokine Signaling Suppression by HPV16 Oncoproteins. PMID: 36342298
Frequent presence of incomplete HPV16 E7 ORFs in lung carcinomas: memories of viral infection. PMID: 20850378
HPV16-transformed human keratinocytes depend on SIX1 expression for proliferation and HPV E6/E7 gene expression. PMID: 31425971
HPV16 E7 protein and hTERT proteins defective for telomere maintenance cooperate to immortalize human keratinocytes. PMID: 23592995
Disruption of HPV16-E7 by CRISPR/Cas system induces apoptosis and growth inhibition in HPV16 positive human cervical cancer cells. PMID: 25136604
The heterogeneous structural behavior of E7 from HPV16 revealed by NMR spectroscopy. PMID: 23940009
HnRNP D activates production of HPV16 E1 and E6 mRNAs by promoting intron retention. PMID: 35234917
Human Papillomavirus 16 E6 and E7 Synergistically Repress Innate Immune Gene Transcription. PMID: 31915229
Realgar, a traditional Chinese medicine, induces apoptosis of HPV16-positive cervical cells through a HPV16 E7-related pathway. PMID: 30410307
Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells. PMID: 30728257
Diagnostic Utility of HPV16 E6 mRNA or E7 mRNA Quantitative Expression for Cervical Cells of Patients with Dysplasia and Carcinoma. PMID: 30056761
T cells specific for HPV16 E7 epitopes in patients with squamous cell carcinoma of the oropharynx. PMID: 16284959
Intrabodies targeting human papillomavirus 16 E6 and E7 oncoproteins for therapy of established HPV-associated tumors. PMID: 33485370
DNA Vaccine Encoding HPV16 Oncogenes E6 and E7 Induces Potent Cell-mediated and Humoral Immunity Which Protects in Tumor Challenge and Drives E7-expressing Skin Graft Rejection. PMID: 28166181
Identification of key amino acid residues that determine the ability of high risk HPV16-E7 to dysregulate major histocompatibility complex class I expression. PMID: 21321113
Detection of HPV E7 Transcription at Single-Cell Resolution in Epidermis. PMID: 29964033
Papillomavirus E7 oncoproteins share functions with polyomavirus small T antigens. PMID: 25540383
HPV-16 E7 Interacts with the Endocytic Machinery via the AP2 Adaptor μ2 Subunit. PMID: 36255238
Genetic variability and functional implication of HPV16 from cervical intraepithelial neoplasia in Shanghai women. PMID: 31670402
Longitudinal Dynamics of HPV16 Antibodies in Saliva and Serum among Pregnant Women. PMID: 36423177
Cellular Functions of HPV16 E5 Oncoprotein during Oncogenic Transformation. PMID: 33106372
A Phase 1 Trial Assessing the Safety and Tolerability of a Therapeutic DNA Vaccination Against HPV16 and HPV18 E6/E7 Oncogenes After Chemoradiation for Cervical Cancer. PMID: 32151670
A Drosophila model of HPV16-induced cancer reveals conserved disease mechanism. PMID: 36508448
Immunocytochemical detection of HPV16 E7 in cervical smear. PMID: 18059138
Identification of host transcriptional networks showing concentration-dependent regulation by HPV16 E6 and E7 proteins in basal cervical squamous epithelial cells. PMID: 27457222
Nuclear import of high risk HPV16 E7 oncoprotein is mediated by its zinc-binding domain via hydrophobic interactions with Nup62. PMID: 24074597
HPV-inactive cell populations arise from HPV16-transformed human keratinocytes after p53 knockout. PMID: 33321328
Fused toes homolog, a potential molecular regulator of human papillomavirus type 16 E6 and E7 oncoproteins in cervical cancer. PMID: 35421154
Monitoring HPV-16 E7 phosphorylation events. PMID: 28126639
Fungal mannosylation enhances human papillomavirus 16 E7 therapeutic immunity against TC-1 tumors. PMID: 29115562
Carboplatin/paclitaxel, E7-vaccination and intravaginal CpG as tri-therapy towards efficient regression of genital HPV16 tumors. PMID: 31060612
SOX2 as a New Regulator of HPV16 Transcription. PMID: 28678184
Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer. PMID: 21654689
The expression of human papillomavirus type 16 (HPV16 E7) induces cell cycle arrest and apoptosis in radiation and hypoxia resistant glioblastoma cells. PMID: 21850378
Expression and purification of His-tagged HPV16 E7 protein active in pRb binding. PMID: 16814565
Genetic variation in the E6 and E7 genes of human papillomavirus type 16 in northeastern Argentina. PMID: 34569642
Genetic Variability in the E6, E7, and L1 Genes of Human Papillomavirus Types 16 and 18 among Women in Saudi Arabia. PMID: 36680149
Human papillomavirus 16-encoded E7 protein inhibits IFN-γ-mediated MHC class I antigen presentation and CTL-induced lysis by blocking IRF-1 expression in mouse keratinocytes. PMID: 23956301
Transforming Properties of Beta-3 Human Papillomavirus E6 and E7 Proteins. PMID: 32669468
Human Papillomavirus 16 E6 and E7 Oncoproteins Alter the Abundance of Proteins Associated with DNA Damage Response, Immune Signaling and Epidermal Differentiation. PMID: 36016386
Identification of novel E6-E7 sequence variants of human papillomavirus 16. PMID: 23208280
A Luminescence-Based Method for In Vitro Screening of Immunomodulatory Checkpoints and Therapeutics., PMID:40402459
Immunization with recombinant HPV16-E7d in fusion with Flagellin as a cancer vaccine: Effect of antigen-adjuvant orientation on the immune response pattern., PMID:39939497
Development and evaluation of a novel E7 multi-epitopic vaccine for human papillomavirus type 16: design, expression, purification, and immunological characterization., PMID:39910471
HPV16 mutant E6/E7 construct is protective in mouse model., PMID:39350162
MAL expression downregulation through suppressive H3K27me3 marks at the promoter in HPV16-related cervical cancers is prognostically relevant and manifested by the interplay of novel MAL antisense long noncoding RNA AC103563.8, E7 oncoprotein and EZH2., PMID:38461243
Evaluation of HPV 16 and HPV 18 Oncoprotein Expression as Alternative Diagnostic Tools in Cervical Lesion., PMID:38415538
A Therapeutic DNA Vaccine Targeting HPV16 E7 in Combination with Anti-PD-1/PD-L1 Enhanced Tumor Regression and Cytotoxic Immune Responses., PMID:37895145
Skin-Grafting and Dendritic Cell "Boosted" Humanized Mouse Models Allow the Pre-Clinical Evaluation of Therapeutic Cancer Vaccines., PMID:37626903
A luminescence-based method to assess antigen presentation and antigen-specific T cell responses for in vitro screening of immunomodulatory checkpoints and therapeutics., PMID:37559730
HPV types 16/18 L1 E6 and E7 proteins seropositivity and cervical cancer risk in HIV-positive and HIV-negative black South African women., PMID:35351184
Immunohistochemical Detection of Human Papillomavirus 16 E7 Oncoprotein in Cervical Lesions., PMID:34729114
Targeting Human Papillomavirus-Associated Cancer by Oncoprotein-Specific Recombinant Antibodies., PMID:34502053
Potent, Selective CARs as Potential T-Cell Therapeutics for HPV-positive Cancers., PMID:34432728
Antigen Delivery to DEC205+ Dendritic Cells Induces Immunological Memory and Protective Therapeutic Effects against HPV-Associated Tumors at Different Anatomical Sites., PMID:34345218
Serum HPV16 E7 Oncoprotein Is a Recurrence Marker of Oropharyngeal Squamous Cell Carcinomas., PMID:34282779
Enhancing immunogenicity of HPV16 E7 DNA vaccine by conjugating codon-optimized GM-CSF to HPV16 E7 DNA., PMID:34247810
Investigating the association between serum human papillomavirus type 16 E7 antibodies and risk of head and neck cancer., PMID:33949155
ePCL Electrospun Microfibrous Layers for Immune Assays: Sensitive ELISA for the Detection of Serum Antibodies Against HPV16 E7 Oncoprotein., PMID:33842749
Combination of a T cell activating therapy and anti-phosphatidylserine enhances anti-tumour immune responses in a HPV16 E7-expressing C3 tumour model., PMID:33627686
Intrabodies targeting human papillomavirus 16 E6 and E7 oncoproteins for therapy of established HPV-associated tumors., PMID:33485370
Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody., PMID:33468698
Evaluation of HPV16 E7 expression in head and neck carcinoma cell lines and clinical specimens., PMID:33335126
PD-1 blockade synergizes with intratumoral vaccination of a therapeutic HPV protein vaccine and elicits regression of tumor in a preclinical model., PMID:33108473
A phase 1, single centre, open label, escalating dose study to assess the safety, tolerability and immunogenicity of a therapeutic human papillomavirus (HPV) DNA vaccine (AMV002) for HPV-associated head and neck cancer (HNC)., PMID:32918586
Epitope Mapping and Computational Analysis of Anti-HPV16 E6 and E7 Antibodies in Single-Chain Format for Clinical Development as Antitumor Drugs., PMID:32640530
A preliminary study on the immune responses of HPV16-E7 by combined intranasal immunization with lymphotoxin., PMID:32627150
Immunomodulation to enhance the efficacy of an HPV therapeutic vaccine., PMID:32554612
Development and validation of a multiplex immunoassay for the simultaneous quantification of type-specific IgG antibodies to E6/E7 oncoproteins of HPV16 and HPV18., PMID:32214362
Preparation, Characterization and Diagnostic Valuation of Two Novel Anti-HPV16 E7 Oncoprotein Monoclonal Antibodies., PMID:32204370
Antibodies against human papillomavirus proteins in Barrett's dysplasia and intramucosal esophageal adenocarcinoma., PMID:32170783
A Phase 1 Trial Assessing the Safety and Tolerability of a Therapeutic DNA Vaccination Against HPV16 and HPV18 E6/E7 Oncogenes After Chemoradiation for Cervical Cancer., PMID:32151670
Annexin A5 as an immune checkpoint inhibitor and tumor-homing molecule for cancer treatment., PMID:32111835
CUE-101, a Novel E7-pHLA-IL2-Fc Fusion Protein, Enhances Tumor Antigen-Specific T-Cell Activation for the Treatment of HPV16-Driven Malignancies., PMID:31964784
FLT3L and granulocyte macrophage colony-stimulating factor enhance the anti-tumor and immune effects of an HPV16 E6/E7 vaccine., PMID:31881013
The Intracellular Delivery Of Anti-HPV16 E7 scFvs Through Engineered Extracellular Vesicles Inhibits The Proliferation Of HPV-Infected Cells., PMID:31806970
TCR sequencing paired with massively parallel 3' RNA-seq reveals clonotypic T cell signatures., PMID:31745340
A phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3., PMID:31576684
Prognostic value of posttreatment HPV-specific antibodies in patients with oropharyngeal tumors., PMID:30986340
Post-treatment human papillomavirus antibody kinetics in cervical cancer patients., PMID:30955486
Nanobody against the E7 oncoprotein of human papillomavirus 16., PMID:30849663
Significance of serum antibodies against HPV E7, Hsp27, Hsp20 and Hp91 in Iranian HPV-exposed women., PMID:30755156
Extracellular overproduction of E7 oncoprotein of Iranian human papillomavirus type 16 by genetically engineered Lactococcus lactis., PMID:30678667
Increased Response of Human T-Lymphocytes by Dendritic Cells Pulsed with HPV16E7 and Pleurotus sajor-caju-β-glucan (PBG)., PMID:30593739
Nuclear lactate dehydrogenase A senses ROS to produce α-hydroxybutyrate for HPV-induced cervical tumor growth., PMID:30356100
Profiling of serum antibodies against human papillomavirus antigens in Korean women with cervical intraepithelial neoplasia and cervical cancer., PMID:30353680
Oral immunization with recombinant Lactococcus lactis NZ9000 expressing human papillomavirus type 16 E7 antigen and evaluation of its immune effects in female C57BL/6 mice., PMID:30192395
Small Heat Shock Proteins B1 and B6: Which One is the Most Effective Adjuvant in Therapeutic HPV Vaccine?, PMID:30171788
Nanoparticle Conjugation of Human Papillomavirus 16 E7-long Peptides Enhances Therapeutic Vaccine Efficacy against Solid Tumors in Mice., PMID:30131378
Mucosal HPV E6/E7 Peptide Vaccination in Combination with Immune Checkpoint Modulation Induces Regression of HPV+ Oral Cancers., PMID:30054333
A novel HPV16 E7-affitoxin for targeted therapy of HPV16-induced human cervical cancer., PMID:30026865
For research use only. Not for human or drug use.
